Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Published:2021-11 Issue:11 Volume:20 Page:917-929
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Uccelli Antonio,Laroni Alice,Ali Rehiana,Battaglia Mario Alberto,Blinkenberg Morten,Brundin Lou,Clanet Michel,Fernandez Oscar,Marriott James,Muraro Paolo,Nabavi Seyed Massood,Oliveri Roberto S,Radue Ernst,Ramo Tello Cristina,Schiavetti Irene,Sellner Johann,Sorensen Per Soelberg,Sormani Maria Pia,Wuerfel Jens Thomas,Freedman Mark S

Funder

Toyota Foundation

United Kingdom Stem Cell Foundation

AFM-Telethon

Multiple Sclerosis Society of Canada

Multiple Sclerosis Society

Carlos III Health Institute

Royan Institute

Multiple Sclerosis International Federation

Danish Multiple Sclerosis Society

European Committee for Treatment and Research in Multiple Sclerosis

Research Manitoba

Fondazione Italiana Sclerosi Multipla

Compagnia di San Paolo

Danish Blood Donor Study

Paracelsus Medizinische Privatuniversitat

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference34 articles.

1. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues;Friedenstein;Transplantation,1968

2. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow;Mezey;Science,2000

3. Biodistribution and clearance of human mesenchymal stem cells by quantitative three-dimensional cryo-imaging after intravenous infusion in a rat lung injury model: MSC tracking by 3D cryo-imaging;Schmuck;Stem Cell Transl Med,2016

4. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis;Gerdoni;Ann Neurol,2007

5. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy;Zappia;Blood,2005

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the interplay between inflammation and stem cell mobilization or homing: Implications for tissue repair and therapeutics;Tzu Chi Medical Journal;2024-09-05

2. Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities;Stem Cell Research & Therapy;2024-08-26

3. Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects;Pharmacological Reports;2024-08-23

4. Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications;European Journal of Pharmacology;2024-08

5. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics;MedComm;2024-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3